These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. Nakayama I; Kawahara Y; Tsuda T; Okuda M; Yokoyama M J Biol Chem; 1994 Apr; 269(15):11628-33. PubMed ID: 7512570 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of cytokine-induced nitric oxide production by transforming growth factor-beta 1 in human smooth muscle cells. Junquero DC; Scott-Burden T; Schini VB; Vanhoutte PM J Physiol; 1992 Aug; 454():451-65. PubMed ID: 1282159 [TBL] [Abstract][Full Text] [Related]
45. Thrombin prevents the expression of inducible nitric oxide synthase in vascular smooth muscle cells by a proteolytically-activated thrombin receptor. Schini-Kerth VB; Fisslthaler B; Andersen TT; Fenton JW; Vanhoutte PM; Busse R Thromb Haemost; 1995 Sep; 74(3):980-6. PubMed ID: 8571333 [TBL] [Abstract][Full Text] [Related]
46. Effects of barbiturates on the expression of the inducible nitric oxide synthase in vascular smooth muscle. Kessler P; Kronemann N; Hecker M; Busse R; Schini-Kerth VB J Cardiovasc Pharmacol; 1997 Dec; 30(6):802-10. PubMed ID: 9436821 [TBL] [Abstract][Full Text] [Related]
47. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Gross SS; Jaffe EA; Levi R; Kilbourn RG Biochem Biophys Res Commun; 1991 Aug; 178(3):823-9. PubMed ID: 1714727 [TBL] [Abstract][Full Text] [Related]
49. Induction of nitric oxide synthase in subsets of murine pulmonary fibroblasts: effect on fibroblast interleukin-6 production. Willis RA; Nussler AK; Fries KM; Geller DA; Phipps RP Clin Immunol Immunopathol; 1994 May; 71(2):231-9. PubMed ID: 7514114 [TBL] [Abstract][Full Text] [Related]
50. Induction of nitric oxide synthase in human vascular smooth muscle: interactions between proinflammatory cytokines. Chester AH; Borland JA; Buttery LD; Mitchell JA; Cunningham DA; Hafizi S; Hoare GS; Springall DR; Polak JM; Yacoub MH Cardiovasc Res; 1998 Jun; 38(3):814-21. PubMed ID: 9747450 [TBL] [Abstract][Full Text] [Related]
51. Interleukin 1 alpha and gamma-interferon induction of nitric oxide production from murine tumor-derived endothelial cells. Chang MJ; Modzelewski RA; Russell DM; Johnson CS Cancer Res; 1996 Feb; 56(4):886-91. PubMed ID: 8631029 [TBL] [Abstract][Full Text] [Related]
52. Characterization of an inhibitor of nitric oxide synthase in human-hand veins. Bedarida GV; Kim D; Blaschke TF; Hoffman BB Horm Metab Res; 1994 Feb; 26(2):109-12. PubMed ID: 7515369 [TBL] [Abstract][Full Text] [Related]
53. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. Beasley D; Schwartz JH; Brenner BM J Clin Invest; 1991 Feb; 87(2):602-8. PubMed ID: 1671393 [TBL] [Abstract][Full Text] [Related]
54. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. McCall TB; Feelisch M; Palmer RM; Moncada S Br J Pharmacol; 1991 Jan; 102(1):234-8. PubMed ID: 1710525 [TBL] [Abstract][Full Text] [Related]
55. Arginine vasopressin inhibits interleukin-1 beta-stimulated nitric oxide and cyclic guanosine monophosphate production via the V1 receptor in cultured rat vascular smooth muscle cells. Kusano E; Tian S; Umino T; Tetsuka T; Ando Y; Asano Y J Hypertens; 1997 Jun; 15(6):627-32. PubMed ID: 9218182 [TBL] [Abstract][Full Text] [Related]
56. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Kilbourn RG; Gross SS; Jubran A; Adams J; Griffith OW; Levi R; Lodato RF Proc Natl Acad Sci U S A; 1990 May; 87(9):3629-32. PubMed ID: 2333306 [TBL] [Abstract][Full Text] [Related]
57. The central effects of a nitric oxide synthase inhibitor (N omega-nitro-L-arginine) on blood pressure and plasma renin. el Karib AO; Sheng J; Betz AL; Malvin RL Clin Exp Hypertens; 1993 Sep; 15(5):819-32. PubMed ID: 7691341 [TBL] [Abstract][Full Text] [Related]
58. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses. López RM; Pérez T; Castillo C; Castillo MC; Castillo EF Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990 [TBL] [Abstract][Full Text] [Related]
59. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. Busse R; Mülsch A FEBS Lett; 1990 Nov; 275(1-2):87-90. PubMed ID: 1702067 [TBL] [Abstract][Full Text] [Related]
60. CGRP enhances induction of NO synthase in vascular smooth muscle cells via a cAMP-dependent mechanism. Schini-Kerth VB; Fisslthaler B; Busse R Am J Physiol; 1994 Dec; 267(6 Pt 2):H2483-90. PubMed ID: 7528998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]